ReviewJournal of cardiovascular translational research2008
Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.
Review in Journal of cardiovascular translational research, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- All Along the Watchtower: a Case of Long QT Syndrome Misdiagnosis Secondary to Genetic Testing Misinterpretation.Journal of genetic counseling · 2018Article
- The Genetic Counselor in the Pediatric Arrhythmia Clinic: Review and Assessment of Services.Journal of genetic counseling · 2018Review
- Article
- A Review of the Giant Protein Titin in Clinical Molecular Diagnostics of Cardiomyopathies.Frontiers in cardiovascular medicine · 2016Review
- Evolving Approaches to Genetic Evaluation of Specific Cardiomyopathies.Current heart failure reports · 2015Review
- The electronic health record for translational research.Journal of cardiovascular translational research · 2014Review
- Using genetic testing to guide therapeutic decisions in cardiomyopathy.Current treatment options in cardiovascular medicine · 2013Article
- Peripartum cardiomyopathy: moving towards a more central role of genetics.Current cardiology reviews · 2013Review
- Genetic testing in the contemporary diagnosis of cardiomyopathy.Current heart failure reports · 2013Review
- Molecular genetics made simple.Global cardiology science & practice · 2012Review
- Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.Journal of the American College of Cardiology · 2011Review
- Clinical and genetic issues in dilated cardiomyopathy: a review for genetics professionals.Genetics in medicine : official journal of the American College of Medical Genetics · 2010Article
- Progress with genetic cardiomyopathies: screening, counseling, and testing in dilated, hypertrophic, and arrhythmogenic right ventricular dysplasia/cardiomyopathy.Circulation. Heart failure · 2009Review
- Building a program in translational genomics.Journal of cardiovascular translational research · 2008Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular genetic medicine is devoted to the identification and understanding of cardiac conditions resulting from genetic and genomic mechanisms and to the development and validation of diagnostic and treatment algorithms and guidelines. Cardiovascular genetic medicine clinics now provide expert cardiovascular subspecialty care, genetic counseling and clinical genetic testing, and will eventually provide disease-specific gene or genetic therapies. Currently, the most tractable diagnoses for cardiovascular genetic medicine are the single-gene disorders: the cardiomyopathies, the channelopathies, and others. The recent explosion of genetic knowledge within the single-gene disorders and consequent rapid proliferation of genetic testing enables far greater numbers of individuals to directly benefit from this progress. A compelling rationale exists for this approach: cardiovascular single-gene diseases commonly present with life-threatening events (e.g., sudden cardiac death, heart failure, stroke, etc.), but identification, evaluation, and treatment of individuals with presymptomatic genetic risk has the promise to prevent or ameliorate cardiovascular morbidity and mortality. Cardiovascular genetic medicine programs also anchor training and research, thereby enabling the next generation of academic specialists in cardiovascular genetic medicine to continue to improve cardiovascular health.
Indexed as
Identifiers
20559908What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.